Showing results (5071-5080 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 28, 2014
Adjuvant therapy for renal cell carcinoma: past, present, and futureSumanta K Pal, Naomi B Haas
The Oncologist|June 28, 2014
The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careEmanuela Vaccher, Diego Serraino, Antonino Carbone, et al.
The Oncologist|June 22, 2014
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in CanadaAlexander V Louie, George B Rodrigues, David A Palma, et al.
The Oncologist|June 22, 2014
Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosisAshley H Woodson, Kimberly I Muse, Heather Lin, et al.
The Oncologist|May 29, 2014
Patterns of storage, use, and disposal of opioids among cancer outpatientsAkhila Reddy, Maxine de la Cruz, Eden Mae Rodriguez, et al.
The Oncologist|May 30, 2014
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphomaCinzia Pellegrini, Lisa Argnani, Alessandro Broccoli, et al.
The Oncologist|May 30, 2014
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRASandra M Swain, Young-Hyuck Im, Seock-Ah Im, et al.
The Oncologist|March 29, 2021
Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case SeriesSebastian F Winter, Deborah A Forst, Derek H Oakley, et al.
The Oncologist|July 11, 2020
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal CancerAfsaneh Barzi, April Choi, Denice Tsao-Wei, et al.
The Oncologist|April 1, 2021
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor TherapiesAndrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, et al.
Pageof 571